About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Mayo Clinic
›
Division of Hematology
›
Top Articles
Division of Hematology
Mayo Clinic
8.1K
Articles
237.5K
Citations
3.1
avg. Impact Factor
199
h-index
Most Cited Articles of Division of Hematology in 2013
Title
Journal
Year
Citations
Mutations and prognosis in primary myelofibrosis
Leukemia
2013
520
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Mayo Clinic Proceedings
2013
341
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience
Gut
2013
276
Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma
Cancer Cell
2013
242
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Leukemia
2013
222
How I treat monoclonal gammopathy of renal significance (MGRS)
Blood
2013
197
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
Leukemia
2013
187
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
Leukemia and Lymphoma
2013
177
Cold agglutinin disease
Blood
2013
168
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
Leukemia
2013
168
Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
Blood
2013
159
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma
Leukemia
2013
158
Carfilzomib
Blood
2013
152
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma
Leukemia
2013
152
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
Leukemia
2013
151
Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
British Journal of Haematology
2013
151
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
Nature Genetics
2013
147
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
Bone Marrow Transplantation
2013
124
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
Cancer
2013
121
Implantable cardioverter defibrillators in patients with cardiac amyloidosis
Journal of Cardiovascular Electrophysiology
2013
118
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
Leukemia
2013
116
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era
American Journal of Transplantation
2013
116
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
Leukemia
2013
113
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance
American Journal of Hematology
2013
112
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study
Annals of Oncology
2013
93
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.